市場調査レポート

商品コード

1229673

リンパ浮腫治療の世界市場：2030年までの予測

Lymphedema Treatment Market Research Report Forecast to 2030

出版日: 2023年03月03日 | 発行: Market Research Future

| ページ情報: 英文 110 Pages | 納期: お問合せ

価格

PDF (Single User License)

USD 4,950 775,962円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。

PDF (Multi User License)

USD 5,950 932,722円

レポートPDFを同一企業内の最大10名がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。

PDF (Enterprise License)

USD 7,250 1,136,510円

レポートPDFを同一企業内のすべての方がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のリンパ浮腫治療の市場規模は、2030年までの調査期間中に8.80%のCAGRで成長し、7億3,100万米ドルに達すると予測されています。悪性成長疾患の症例の増加、公的機関による強力な推進は、市場の成長を促進しています。

当レポートでは、世界のリンパ浮腫治療市場について調査分析し、市場力学、市場分析、企業情勢、企業プロファイルなど、体系的な情報を提供しています。

LIST OF TABLES

TABLE 1 GLOBAL LYMPHEDEMA TREATMENT MARKET SYNOPSIS, 2022-2030
TABLE 2 GLOBAL LYMPHEDEMA TREATMENT MARKET ESTIMATES & FORECAST, 2022-2030(USD MILLION)
TABLE 3 GLOBAL LYMPHEDEMA TREATMENT MARKET, BY TYPE, 2022-2030(USD MILLION)
TABLE 4 GLOBAL LYMPHEDEMA TREATMENT MARKET, BY AFFECTED AREA, 2022-2030(USD MILLION)
TABLE 5 GLOBAL LYMPHEDEMA TREATMENT MARKET, BY TREATMENT, 2022-2030(USD MILLION)
TABLE 6 GLOBAL LYMPHEDEMA TREATMENT MARKET, BY END USER, 2022-2030(USD MILLION)
TABLE 7 GLOBAL LYMPHEDEMA TREATMENT MARKET, BY REGION, 2022-2030(USD MILLION)
TABLE 8 NORTH AMERICA: LYMPHEDEMA TREATMENT MARKET, BY TYPE, 2022-2030(USD MILLION)
TABLE 9 NORTH AMERICA: LYMPHEDEMA TREATMENT MARKET, BY AFFECTED AREA, 2022-2030(USD MILLION)
TABLE 10 NORTH AMERICA: LYMPHEDEMA TREATMENT MARKET, BY TREATMENT, 2022-2030(USD MILLION)
TABLE 11 NORTH AMERICA: LYMPHEDEMA TREATMENT MARKET, BY END USER, 2022-2030(USD MILLION)
TABLE 12 US: LYMPHEDEMA TREATMENT MARKET, BY TYPE, 2022-2030(USD MILLION)
TABLE 13 US: LYMPHEDEMA TREATMENT MARKET, BY AFFECTED AREA, 2022-2030(USD MILLION)
TABLE 14 US: LYMPHEDEMA TREATMENT MARKET, BY TREATMENT, 2022-2030(USD MILLION)
TABLE 15 US: LYMPHEDEMA TREATMENT MARKET, BY END USER, 2022-2030(USD MILLION)
TABLE 16 CANADA: LYMPHEDEMA TREATMENT MARKET, BY TYPE, 2022-2030(USD MILLION)
TABLE 17 CANADA: LYMPHEDEMA TREATMENT MARKET, BY AFFECTED AREA, 2022-2030(USD MILLION)
TABLE 18 CANADA: LYMPHEDEMA TREATMENT MARKET, BY TREATMENT, 2022-2030(USD MILLION)
TABLE 19 CANADA: LYMPHEDEMA TREATMENT MARKET, BY END USER, 2022-2030(USD MILLION)
TABLE 20 LATIN AMERICA: LYMPHEDEMA TREATMENT MARKET, BY TYPE, 2022-2030(USD MILLION)
TABLE 21 LATIN AMERICA: LYMPHEDEMA TREATMENT MARKET, BY AFFECTED AREA, 2022-2030(USD MILLION)
TABLE 22 LATIN AMERICA: LYMPHEDEMA TREATMENT MARKET, BY TREATMENT, 2022-2030(USD MILLION)
TABLE 23 LATIN AMERICA: LYMPHEDEMA TREATMENT MARKET, BY END USER, 2022-2030(USD MILLION)
TABLE 24 EUROPE: LYMPHEDEMA TREATMENT MARKET, BY TYPE, 2022-2030(USD MILLION)
TABLE 25 EUROPE: LYMPHEDEMA TREATMENT MARKET, BY AFFECTED AREA, 2022-2030(USD MILLION)
TABLE 26 EUROPE: LYMPHEDEMA TREATMENT MARKET, BY TREATMENT, 2022-2030(USD MILLION)
TABLE 27 EUROPE: LYMPHEDEMA TREATMENT MARKET, BY END USER, 2022-2030(USD MILLION)
TABLE 28 WESTERN EUROPE: LYMPHEDEMA TREATMENT MARKET, BY TYPE, 2022-2030(USD MILLION)
TABLE 29 WESTERN EUROPE: LYMPHEDEMA TREATMENT MARKET, BY AFFECTED AREA, 2022-2030(USD MILLION)
TABLE 30 WESTERN EUROPE: LYMPHEDEMA TREATMENT MARKET, BY TREATMENTT, 2022-2030(USD MILLION)
TABLE 31 WESTERN EUROPE: LYMPHEDEMA TREATMENT MARKET, BY END USER, 2022-2030(USD MILLION)
TABLE 32 EASTERN EUROPE: LYMPHEDEMA TREATMENT MARKET, BY TYPE, 2022-2030(USD MILLION)
TABLE 33 EASTERN EUROPE: LYMPHEDEMA TREATMENT MARKET, BY AFFECTED AREA, 2022-2030(USD MILLION)
TABLE 34 EASTERN EUROPE: LYMPHEDEMA TREATMENT MARKET, BY TREATMENT, 2022-2030(USD MILLION)
TABLE 35 EASTERN EUROPE: LYMPHEDEMA TREATMENT MARKET, BY END USER, 2022-2030(USD MILLION)
TABLE 36 ASIA-PACIFIC: LYMPHEDEMA TREATMENT MARKET, BY TYPE, 2022-2030(USD MILLION)
TABLE 37 ASIA-PACIFIC: LYMPHEDEMA TREATMENT MARKET, BY AFFECTED AREA, 2022-2030(USD MILLION)
TABLE 38 ASIA-PACIFIC: LYMPHEDEMA TREATMENT MARKET, BY TREATMENT, 2022-2030(USD MILLION)
TABLE 39 ASIA-PACIFIC: LYMPHEDEMA TREATMENT MARKET, BY END USER, 2022-2030(USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA: LYMPHEDEMA TREATMENT MARKET, BY TYPE, 2022-2030(USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA: LYMPHEDEMA TREATMENT MARKET, BY AFFECTED AREA, 2022-2030(USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA: LYMPHEDEMA TREATMENT MARKET, BY TREATMENT, 2022-2030(USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA: LYMPHEDEMA TREATMENT MARKET, BY END USER, 2022-2030(USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL LYMPHEDEMA TREATMENT MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL LYMPHEDEMA TREATMENT MARKET
FIGURE 4 GLOBAL LYMPHEDEMA TREATMENT MARKET SHARE, BY TYPE, 2022 (%)
FIGURE 5 GLOBAL LYMPHEDEMA TREATMENT MARKET SHARE, BY AFFECTED AREA, 2022 (%)
FIGURE 6 GLOBAL LYMPHEDEMA TREATMENT MARKET SHARE, BY TREATMENT, 2022 (%)
FIGURE 7 GLOBAL LYMPHEDEMA TREATMENT MARKET SHARE, BY END USER, 2022 (%)
FIGURE 8 GLOBAL LYMPHEDEMA TREATMENT MARKET SHARE, BY REGION, 2022 (%)
FIGURE 7 AMERICAS: LYMPHEDEMA TREATMENT MARKET SHARE BY REGION, 2022 (%)
FIGURE 9 NORTH AMERICA: LYMPHEDEMA TREATMENT MARKET SHARE, BY COUNTRY, 2022 (%)
FIGURE 10 EUROPE: LYMPHEDEMA TREATMENT MARKET SHARE, BY REGION, 2022 (%)
FIGURE 11 WESTERN EUROPE: LYMPHEDEMA TREATMENT MARKET SHARE, BY COUNTRY, 2022 (%)
FIGURE 12 ASIA-PACIFIC: LYMPHEDEMA TREATMENT MARKET SHARE, BY COUNTRY, 2022 (%)
FIGURE 13 MIDDLE EAST & AFRICA: LYMPHEDEMA TREATMENT MARKET SHARE, BY COUNTRY, 2022 (%)
FIGURE 14 GLOBAL LYMPHEDEMA TREATMENT MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 15 3A HEALTH CARE: KEY FINANCIALS
FIGURE 16 3A HEALTH CARE: SEGMENTAL REVENUE
FIGURE 17 3A HEALTH CARE: REGIONAL REVENUE
FIGURE 18 BIO COMPRESSION SYSTEMS, INC.: KEY FINANCIALS
FIGURE 19 BIO COMPRESSION SYSTEMS, INC.: SEGMENTAL REVENUE
FIGURE 20 BIO COMPRESSION SYSTEMS, INC.: REGIONAL REVENUE
FIGURE 21 DEVON MEDICAL PRODUCTS: KEY FINANCIALS
FIGURE 22 DEVON MEDICAL PRODUCTS: SEGMENTAL REVENUE
FIGURE 23 DEVON MEDICAL PRODUCTS: REGIONAL REVENUE
FIGURE 24 HERANTIS PHARMA PLC: KEY FINANCIALS
FIGURE 25 HERANTIS PHARMA PLC: SEGMENTAL REVENUE
FIGURE 26 HERANTIS PHARMA PLC: REGIONAL REVENUE
FIGURE 27 LOHMANN & RAUSCHER: KEY FINANCIALS
FIGURE 28 LOHMANN & RAUSCHER: SEGMENTAL REVENUE
FIGURE 29 LOHMANN & RAUSCHER: REGIONAL REVENUE
FIGURE 30 MEGO AFEK LTD: KEY FINANCIALS
FIGURE 31 MEGO AFEK LTD: SEGMENTAL REVENUE
FIGURE 32 MEGO AFEK LTD: REGIONAL REVENUE
FIGURE 33 SIGVARIS: KEY FINANCIALS
FIGURE 34 SIGVARIS: SEGMENTAL REVENUE
FIGURE 35 SIGVARIS: REGIONAL REVENUE
FIGURE 36 TACTILE SYSTEMS TECHNOLOGY INC.: KEY FINANCIALS
FIGURE 37 TACTILE SYSTEMS TECHNOLOGY INC.: SEGMENTAL REVENUE
FIGURE 38 TACTILE SYSTEMS TECHNOLOGY INC.: REGIONAL REVENUE
FIGURE 39 WRIGHT THERAPY PRODUCTS (BSN MEDICAL): KEY FINANCIALS
FIGURE 40 WRIGHT THERAPY PRODUCTS (BSN MEDICAL): SEGMENTAL REVENUE
FIGURE 41 WRIGHT THERAPY PRODUCTS (BSN MEDICAL): REGIONAL REVENUE

Product Code: MRFR/HC/6968-HCR

Market Overview

The lymphedema treatment market is expected to arrive at USD 731 Million by 2030 at 8.80% CAGR during the estimated time frame. Lymphedema happens when the lymph liquids amass on the greasy tissues under the skin. This is basically caused because of the unpredictable stream in the lymphatic framework. It is seen in the legs, arms as well as feet.

Individuals across the world are getting impacted by sickness. Thus, the interest in compelling treatment is likewise expanding. Subsequently, the Lymphedema Treatment Market Examination recommends that the market will develop at a huge rate in the conjecture period. Asia-Pacific region is assessed to witness the quickest CAGR in the estimated period. The Lymphedema Treatment Market is supposed to develop at a critical rate because of the help of different drivers like expanding instances of malignant growth illnesses. Likewise, the strong drives by the public authority and repayment arrangements will be good for market development.

Market Segmentations

The Lymphedema Treatment Market Size is separated into various fragments like treatment, type, the impacted region, and end-client. Considering treatment, the market is separated into Wraps and Packing Gadgets, Medication Treatment, Laser Treatment, Medical procedures, and Others.

In terms of type, the Lymphedema Treatment Market is divided into Auxiliary Lymphedema and Essential Lymphedema. Essential lymphedema is caused because of the advancement of a strange bunch of lymph. By the impacted region, the market is bifurcated into Furthest point, Lower Limit, and Genitalia. The furthest point is one of the confounded illnesses and the lower limit region includes enlarging of feet, legs, and lower legs. Based on end-client, the Lymphedema Treatment Market is partitioned into Facilities and Emergency clinics, Scholarly and Exploration Foundations, and Clinical Exploration Associations.

Regional Analysis

The Americas is likely to have the biggest portion of the market. Mostly, because of the expanded instances of disease and the rise of different central participants, the region is supposed to have a huge offer.

Furthermore, Europe is assessed to partake in the second-biggest Lymphedema Treatment Market Offer. The rising expenditure for medical care and strong drives by the public authority for lymphedema treatment is the urgent purposes behind the extraordinary development.

Thirdly, the Asia-Pacific region is expected to hold the biggest offer in the market. Nations, for example, India and China are creating at a fast speed which is assessed to emphatically affect the Lymphedema Treatment Market Development.

Furthermore, Africa and the Center East region are supposed to have a minimal offer in the market. The low improvement of medical care and severe guidelines by the public authority is controlling the market development around here.

Major Players

The key players in the market are Mego Afek Ltd. (US), Bio Compression Systems Inc. (US), SIGVARIS (Switzerland), Herantis Pharma PLC (Finland), 3A Health Care (Italy), Wright Therapy Products (Germany), Tactile Systems Technology Inc. (US), Lohmann & Rausher (Germany), Juzo (Germany), 3M (US), Cardinal Health (US), Huntleigh Healthcare Limited (UK), Koya Medical (US), Avet Pharmaceuticals (US), AIROS Medical Inc. (US), and Convatec (UK).

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

TABLE OF CONTENTS

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. DEFINITION
2.2. SCOPE OF THE STUDY
- 2.2.1. RESEARCH OBJECTIVE
- 2.2.2. ASSUMPTIONS
- 2.2.3. LIMITATIONS

3. RESEARCH METHODOLOGY

3.1. OVERVIEW
3.2. PRIMARY RESEARCH
3.3. SECONDARY RESEARCH
3.4. MARKET SIZE ESTIMATION

4. MARKET DYNAMICS

4.1. OVERVIEW
4.2. DRIVERS
4.3. RESTRAINTS
4.4. OPPORTUNITIES